Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. (ARMP) is a Biotechnology company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Armata Pharmaceuticals, Inc. in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Exchange
- New York Stock Exchange
- CEO
- Deborah L. Birx
- Employees
- 60
- IPO date
- 20 May 1994
- ISIN
- US04216R1023
- Website
- armatapharma.com
Frequently asked questions
Where is Armata Pharmaceuticals, Inc. stock listed?
Armata Pharmaceuticals, Inc. (ARMP) is listed on New York Stock Exchange.